Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (816)
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
320
Price
$522.39
Total Value
$167.17K
Shares Held After
45,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,308
Price
$521.50
Total Value
$682.12K
Shares Held After
45,492
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
360
Price
$518.82
Total Value
$186.78K
Shares Held After
46,800
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
780
Price
$517.94
Total Value
$403.99K
Shares Held After
47,160
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,617
Price
$516.93
Total Value
$835.87K
Shares Held After
47,940
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,360
Price
$515.93
Total Value
$701.67K
Shares Held After
49,557
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,795
Price
$514.82
Total Value
$924.11K
Shares Held After
50,917
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
760
Price
$512.92
Total Value
$389.82K
Shares Held After
52,712
% of Holdings
1.4%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
5,000
Price
$0.26
Total Value
$1.29K
Shares Held After
31,294
% of Holdings
16.0%
Adagene Inc. (ADAG)
Luo Peter — Director
Shares
279
Price
$3.65
Total Value
$1.02K
Shares Held After
68,245
% of Holdings
0.4%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
10,000
Price
$0.98
Total Value
$9.82K
Shares Held After
1,993,551
% of Holdings
0.5%
Fortrea Holdings Inc. (FTRE)
Thakral Anshul — Director
Shares
50,417
Price
$19.28
Total Value
$972.04K
Shares Held After
316,797
% of Holdings
13.7%
Fortrea Holdings Inc. (FTRE)
Thakral Anshul — Director
Shares
49,452
Price
$19.03
Total Value
$941.07K
Shares Held After
367,214
% of Holdings
11.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$524.59
Total Value
$83.93K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
261
Price
$523.88
Total Value
$136.73K
Shares Held After
324,603
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
939
Price
$522.66
Total Value
$490.78K
Shares Held After
324,864
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,385
Price
$521.64
Total Value
$722.48K
Shares Held After
325,803
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,011
Price
$520.58
Total Value
$526.30K
Shares Held After
327,188
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,496
Price
$519.62
Total Value
$777.35K
Shares Held After
328,199
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,891
Price
$518.51
Total Value
$980.50K
Shares Held After
329,695
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
557
Price
$517.48
Total Value
$288.24K
Shares Held After
331,586
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
386
Price
$516.72
Total Value
$199.46K
Shares Held After
332,143
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
205
Price
$515.44
Total Value
$105.67K
Shares Held After
332,529
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
529
Price
$514.28
Total Value
$272.05K
Shares Held After
332,734
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$511.07
Total Value
$40.89K
Shares Held After
333,263
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$510.28
Total Value
$81.64K
Shares Held After
333,343
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$507.24
Total Value
$81.16K
Shares Held After
333,503
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$504.31
Total Value
$40.34K
Shares Held After
333,663
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$502.29
Total Value
$100.46K
Shares Held After
333,743
% of Holdings
0.1%
Tiziana Life Sciences Ltd (TLSA)
Elrifi Ivor — Chief Executive Officer
Shares
237,616
Price
$1.00
Total Value
$237.62K
Shares Held After
4,793,684
% of Holdings
5.0%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
4,356
Price
$25.00
Total Value
$108.90K
Shares Held After
117,227
% of Holdings
3.6%
Vaxcyte, Inc. (PCVX)
Dhaliwal Harpreet S. — Chief Technical Ops Officer
Shares
17,000
Price
$55.00
Total Value
$935.07K
Shares Held After
76,756
% of Holdings
18.1%
Enliven Therapeutics, Inc. (ELVN)
Derynck Mika K — Director
Shares
158,795
Price
$60.21
Total Value
$9.56M
Shares Held After
0
% of Holdings
100.0%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
3,700
Price
$113.12
Total Value
$418.56K
Shares Held After
3,985
% of Holdings
48.1%
Adagene Inc. (ADAG)
Luo Peter — Director
Shares
22,966
Price
$3.65
Total Value
$83.75K
Shares Held After
67,966
% of Holdings
33.8%
Immunome Inc. (IMNM)
Horn Kinney — CHIEF BUSINESS OFFICER
Shares
90,616
Price
$25.09
Total Value
$2.27M
Shares Held After
0
% of Holdings
100.0%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
10,292
Price
$68.57
Total Value
$705.72K
Shares Held After
383,868
% of Holdings
2.6%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
30,000
Price
$3.25
Total Value
$97.50K
Shares Held After
6,188,287
% of Holdings
0.5%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
30,000
Price
$30.48
Total Value
$914.40K
Shares Held After
54,645
% of Holdings
35.4%
Acrivon Therapeutics, Inc. (ACRV)
Levy Adam D. — Chief Financial Officer
Shares
1,142
Price
$1.57
Total Value
$1.79K
Shares Held After
66,008
% of Holdings
1.7%
Tiziana Life Sciences Ltd (TLSA)
Elrifi Ivor — Chief Executive Officer
Shares
83,807
Price
$0.97
Total Value
$81.29K
Shares Held After
4,556,068
% of Holdings
1.8%
MBX Biosciences, Inc. (MBX)
Azoulay Salomon — Chief Medical Officer
Shares
370
Price
$65.77
Total Value
$24.33K
Shares Held After
14,399
% of Holdings
2.5%
FATE THERAPEUTICS INC (FATE)
Valamehr Bahram — Director
Shares
43,947
Price
$2.46
Total Value
$108.10K
Shares Held After
591,815
% of Holdings
6.9%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
26,842
Price
$10.23
Total Value
$274.60K
Shares Held After
844,895
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
299
Price
$520.49
Total Value
$155.63K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
517
Price
$519.50
Total Value
$268.58K
Shares Held After
324,742
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,446
Price
$518.40
Total Value
$749.60K
Shares Held After
325,259
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,142
Price
$517.50
Total Value
$1.63M
Shares Held After
326,705
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,456
Price
$516.59
Total Value
$1.27M
Shares Held After
329,847
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
605
Price
$515.50
Total Value
$311.88K
Shares Held After
332,303
% of Holdings
0.2%
Showing 1–50 of 816 transactions (page 1 of 17)